Bluejay Diagnostics, Inc.
BJDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,718 | -$9,954 | -$9,297 | -$3,488 |
| Dep. & Amort. | $199 | $781 | $306 | $146 |
| Deferred Tax | $0 | $0 | $0 | $171 |
| Stock-Based Comp. | $20 | $189 | $433 | $68 |
| Change in WC | -$633 | $667 | $579 | -$1,485 |
| Other Non-Cash | $312 | $3 | $237 | $222 |
| Operating Cash Flow | -$7,820 | -$8,314 | -$7,742 | -$4,367 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$307 | -$704 | -$1,199 | -$24 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$307 | -$704 | -$1,199 | -$24 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$5 | -$5 | -$1 | $4,201 |
| Stock Issued | $12,069 | $160 | $9 | $18,856 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | -$18 |
| Other Fin. Act. | -$1,844 | $957 | $0 | -$513 |
| Financing Cash Flow | $10,220 | $1,112 | $8 | $22,526 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2,093 | -$7,906 | -$8,933 | $18,135 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,209 | $10,115 | $19,048 | $912 |
| End Cash | $4,302 | $2,209 | $10,115 | $19,048 |
| Free Cash Flow | -$8,127 | -$9,018 | -$8,941 | -$4,391 |